US stocks rebounded, shocking Wall Street! This week's focus will shift to the "Hart's first debate" and CPI data.
①After last week's sharp drop in US stocks triggered by economic concerns, a new wave of bottom-buying stimulated a rebound in the stock market on Monday; ②Looking ahead to this week, traders are closely watching the US inflation data scheduled for release on Wednesday, in search of clues on the scale of the Fed's interest rate cuts; ③In addition, the first presidential debate between Harris and Trump on Tuesday night also attracted the attention of many industry insiders.
Here's How Much $1000 Invested In Reliance 10 Years Ago Would Be Worth Today
Peering Into Avantor's Recent Short Interest
Oppenheimer Lists Best Stock Ideas Into the 2024 U.S. Elections
Reliance Global Says Cash Required to Close Spetner Associates Reduced
EXCLUSIVE: Reliance Global Cuts Cash Payment for Spetner Deal, Expects Revenue to Double
EXCLUSIVE: Reliance Global Tells Benzinga 'Reaffirmed That the Transaction Remains on Track and Is Anticipated to Close, as Announced, in the Second Half of 2024'
EXCLUSIVE: Reliance Global Tells Benzinga 'Cash Required to Close Reduced by Over $2 Million'
CNH Industrial, Parsons and More Join S&P MidCap 400
Insider Trades: Notables Buy and Sell by Significant Shareholders, Executives and Directors
Peering Into EMCOR Group's Recent Short Interest
Here's How Much You Would Have Made Owning Burlington Stores Stock In The Last 10 Years
Looking Into Carlisle Companies's Recent Short Interest
BioMarin Restructures, Outlines Roadmap To $4B Revenues By 2027
Biomarin Pharmaceutical Analyst Ratings
'Trump Trade' vs. 'Harris Trade': How They Could Shape Your Portfolio
IJH ETF Falls Wednesday
BioMarin Plans $500M Cost Transformation to Improve Margins
BioMarin Pharmaceutical Shares Resume Trade
Carlisle Companies Analyst Ratings